Samsung Bioepis and Samsung Medical Center Launch Joint Research on New Drug Development Based on Medical Data

Joint Research and Advisory Committee to Operate Through 2030

Building AI-Based Patient Treatment Technologies and New Drug Target Discovery Platform

Samsung Bioepis and Samsung Medical Center are launching a joint research initiative to secure next-generation bio-technologies based on medical data.

Kim Kyung-Ah, President of Samsung Bioepis (left), and Park Seung-Woo, Director of Samsung Medical Center, are signing a joint research agreement and taking a commemorative photo at the Samsung Bioepis headquarters in Songdo, Incheon. Samsung Bioepis

On June 1, Samsung Bioepis announced that it had signed a joint research agreement in the biomedical field with Samsung Medical Center.

The two organizations plan to operate a consultative body and a research advisory committee and jointly carry out a range of research projects through the end of 2030.

The core of this agreement is research utilizing medical data held by Samsung Medical Center. Samsung Bioepis plans to incorporate artificial intelligence (AI) to develop patient treatment technologies and build a new drug target discovery platform. The company also intends to use the data acquired during the research process for new drug development, including antibody-drug conjugates (ADCs), and for establishing clinical strategies.

Kim Kyung-Ah, President of Samsung Bioepis, stated, "We will leverage Samsung's healthcare ecosystem to address unmet medical needs and lay the foundation for leading technological innovation," adding, "Together with Samsung Medical Center, we aim to achieve research outcomes that can improve patients' quality of life."

Park Seungwoo, Director of Samsung Medical Center, commented, "The future of medicine lies in realizing ultra-precision healthcare," and added, "Through our collaboration with Samsung Bioepis, we will accelerate the future of medicine and enhance the global competitiveness of Korea's medical sector."

This content was produced with the assistance of AI translation services.